Plasma levels of CXCL4 are associated with tumour vascularity. Increased CXCL4 levels in NSCLC patients undergoing treatment may indicate active cancer-induced angiogenesis associated with relapse and worse outcome.
Background: Measuring levels of ligands in peripheral blood representing systemic circulation and in blood isolated from tumour vascular bed accompanied by evaluation of binding receptor expression in tumour tissue gives insight into cancerogenesis. We have incorporated this research strategy into surgical practice to investigate the role of CXC chemokines as potential biomarkers of lung cancer. Methods: The study recruited 40 patients (mean age 62±10.4) with primary NSCLC ranging from stage IA to IIB undergoing anatomical pulmonary resection between June 2010 and October 2014. Blood samples from peripheral vein and from pulmonary vein draining tumour vascular bed were collected at the time of surgery. Levels of CXC chemokine ligands (CXCL) potentially involved in cancerogenesis -CXCL1, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, CXCL10, CXCL11 and CXCL12 were measured using ELISA. CXCL gradients were calculated. Corresponding CXC chemokine receptor (CXCR) expression -CXCR1, CXCR2, CXCR3 and CXCR4 was evaluated in resected tumour by immunohistochemistry and analysed semiquantitatively (expression intensity scale 0-3). Prognostic value of CXCL levels and CXCR expression was assessed evaluating relapse time. Paired two-tailed t-test was used to compare CXCL levels and Pearson test was used to assess statistical relationship between CXCL levels and CXCR expression. Results: Statistically significant difference between circulating CXC levels was found for CXCL4 (p < 0.001), CXCL5 (p < 0.05), CXCL7 (p < 0.001). Moderate statistically significant correlation was found between CXCL10, CXCL11 gradient and stromal expression of CXCR3. CXCL1, CXCL4 and CXCL10 gradients correlated with relapse (r = 0.38, r = 0.39, r = 0.35, p < 0.05). CXCR2 expression in tumour tissue correlated with relapse (r = 0.44, p < 0.05) and mortality (r = 0.45, p < 0.05). Conclusions: Our approach has facilitated identifying chemokine ligands and receptors potentially involved in NSCLC tumour metabolism and improved understanding of a complex and variable background of proteomic profile in lung cancer leading to biomarker discovery.
Background:The graphene, an allotrope of carbon, has the honeycombing structure of one-atom-thick planar sheets, is
Conclusion: Differences in the metabolomics profiles were apparent and demonstrated the preliminary feasibility of distinguishing early stage NSCLC cases from controls and adenocarcinomas from squamous cell carcinomas using metabolomics techniques. Validation of this methodology on a larger, prospectively accrued, cohort is planned in order to optimize model fit and to assess the diagnostic and NSCLC subtype discriminatory performance in the clinical setting.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.